SINGLE, ESCALATING DOSE PHARMACOKINETICS, SAFETY, AND FOOD EFFECTS OF A NEW ORAL ANDROGEN 11β-METHYL-19-NORTESTOSTERONE 17β-DODECYLCARBONATE IN MAN: A POTENTIAL ORAL MALE HORMONAL CONTRACEPTIVE

被引：0
|
作者：
Wu, S. [1 ]
Yuen, F. [2 ]
Swerdloff, R. [2 ]
Pak, Y. [2 ]
Liu, P. [2 ]
Bremner, W. [1 ]
Page, S. [1 ]
Wang, C. [2 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] UCLA LABiomed, Los Angeles, CA USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2018年 / 66卷 / 01期
关键词：
D O I：
10.1136/jim-2017-000663.240
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
240
引用
收藏
页码：166 / 166
页数：1
相关论文
共 7 条
  • [1] Single, escalating dose pharmacokinetics, safety and food effects of a new oral androgen dimethandrolone undecanoate in man: a prototype oral male hormonal contraceptive
    Surampudi, P.
    Page, S. T.
    Swerdloff, R. S.
    Nya-Ngatchou, J. J.
    Liu, P. Y.
    Amory, J. K.
    Leung, A.
    Hull, L.
    Blithe, D. L.
    Woo, J.
    Bremner, W. J.
    Wang, C.
    ANDROLOGY, 2014, 2 (04) : 579 - 587
  • [2] Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11β-Methyl-19-Nortestosterone-17β- Dodecylcarbonate in Men
    Wu, Sherry
    Yuen, Fiona
    Swerdloff, Ronald S.
    Pak, Youngju
    Thirumalai, Arthi
    Liu, Peter Y.
    Amory, John K.
    Bai, Feng
    Hull, Laura
    Blithe, Diana L.
    Anawalt, Bradley D.
    Parman, Toufan
    Kim, Kyuri
    Lee, Min S.
    Bremner, William J.
    Page, Stephanie T.
    Wang, Christina
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (03): : 629 - 638
  • [3] Acceptability of the oral hormonal male contraceptive prototype, 11β-methyl-19-nortestosterone dodecylcarbonate (11β-MNTDC), in a 28-day placebo-controlled trial
    Nguyen, Brian T.
    Yuen, Fiona
    Farrant, Maritza
    Thirumalai, Arthi
    Fernando, Frances
    Amory, John K.
    Swerdloff, Ronald S.
    Anawalt, Bradley D.
    Blithe, Diana L.
    Long, Jill E.
    Liu, Peter Y.
    Page, Stephanie T.
    Wang, Christina
    CONTRACEPTION, 2021, 104 (05) : 531 - 537
  • [4] Identification of the Biotransformation Pathways of a Potential Oral Male Contraceptive, 11β-Methyl-19-Nortestosterone (11β-MNT) and Its Prodrugs: An In Vitro Study Highlights the Contribution of Polymorphic Intestinal UGT2B17
    Bachhav, Namrata
    Singh, Dilip Kumar
    Blithe, Diana L.
    Lee, Min S.
    Prasad, Bhagwat
    PHARMACEUTICS, 2024, 16 (08)
  • [5] Comparison of the single dose pharmacokinetics, pharmacodynamics, and safety of two novel oral formulations of dimethandrolone undecanoate (DMAU): a potential oral, male contraceptive
    Ayoub, R.
    Page, S. T.
    Swerdloff, R. S.
    Liu, P. Y.
    Amory, J. K.
    Leung, A.
    Hull, L.
    Blithe, D.
    Christy, A.
    Chao, J. H.
    Bremner, W. J.
    Wang, C.
    ANDROLOGY, 2017, 5 (02) : 278 - 285
  • [6] Long-Term Effects of Dimethandrolone 17β-Undecanoate and 11β-Methyl-19-Nortestosterone 17β-Dodecylcarbonate on Body Composition, Bone Mineral Density, Serum Gonadotropins, and Androgenic/Anabolic Activity in Castrated Male Rats
    Attardi, Barbara J.
    Marck, Brett T.
    Matsumoto, Alvin M.
    Koduri, Sailaja
    Hild, Sheri A.
    JOURNAL OF ANDROLOGY, 2011, 32 (02): : 183 - 192
  • [7] POTENT ORALLY ACTIVE SYNTHETIC ANDROGENS, DIMETHANDROLONE UNDECANOATE (DMAU: 7ALPHA, 11BETA DIMETHYL-19-NORTESTOSTERONE 17BETA-UNDECANOATE) AND 11BETA-METHYL-19-NORTESTOSTERONE 17BETA-DODECYLCARBONATE (11BETA-MNTDC) AS POTENTIAL SINGLE AGENT MALE CONTRACEPTIVES: TESTING IN AN ADULT MALE RABBIT MODEL
    Attardi, Barbara
    Engbring, Jean
    Gropp, David
    Koduri, Sailaja
    Hild, Sheri Ann
    JOURNAL OF ANDROLOGY, 2009, 30 : 91 - 91
1